In the process of China's western development, Otsuka Pharmaceutical Company complied with the strategy of China's western development and invested in Sichuan Otsuka Pharmaceutical Co., Ltd., which is located in Leshan High-tech Development Zone, 50 km southwest of Chengdu. The newly-built modern factory covers an area of 50 mu, which was officially completed and put into operation in July 2003, and passed the national GMP certification on June 26, 2003, and then obtained the GMP certification of Otsuka Pharmaceutical Co., Ltd. in Japan. The company has modern pharmaceutical production lines such as oral liquid, syrup, tablets, capsules, granules, powder/aerosol. The annual production capacity is 2 billion tablets, 300 million hard capsules and 500 million bags of granules, and the liquid processing capacity is 1 1,000 tons.
The company adheres to the policy of "quality is life", strictly abides by GMP operation rules, and strictly controls quality from all aspects to ensure the excellent quality of ex-factory products.
The company has established the corporate philosophy of "disease management and care for patients", based on providing high-quality and low-cost drug solutions for low-income respiratory patients (especially asthma and COPD). Let patients with asthma and chronic obstructive pulmonary disease "breathe freely and enjoy life" is the eternal goal pursued by the company.
The company has 66 generic drugs and new drugs 1 1. The company's main products are: Baishanping (Montelukast Sodium) tablets/chewable tablets, Patentum (ProbCatrau Hydrochloride) aerosol, Tanjing (Ambroxol Hydrochloride) capsules/tablets/oral liquid, levofloxacin hydrochloride capsules and a series of generic products.
In order to let more patients use the high-quality products of Otsuka in Sichuan as soon as possible, the company's sales team actively explores the national market and strives to establish a national sales network. Now it has successfully established a sales team and network covering 26 provinces, municipalities and autonomous regions in China.
The company also actively participated in social welfare undertakings, especially after the May 2008 12 earthquake. As an enterprise in the disaster area, it took the lead in donating medicines, other materials and donations to the worst-hit areas, which was widely praised by all walks of life.
Sichuan Otsuka is a young pharmaceutical company. Through years of hard work, she has shown a good development trend. We have reason to believe that with the warmth of Otsuka Group, under the leadership of Otsuka (China) Investment Co., Ltd. and through the unremitting efforts of all employees in Otsuka, Sichuan, the company will certainly make due contributions to the health cause of China.